163 related articles for article (PubMed ID: 20443090)
1. Antiangiogenic activity of sterically stabilized liposomes containing paclitaxel (SSL-PTX): in vitro and in vivo.
Huang Y; Chen XM; Zhao BX; Ke XY; Zhao BJ; Zhao X; Wang Y; Zhang X; Zhang Q
AAPS PharmSciTech; 2010 Jun; 11(2):752-9. PubMed ID: 20443090
[TBL] [Abstract][Full Text] [Related]
2. Anti-tumor and anti-angiogenic effect of metronomic cyclic NGR-modified liposomes containing paclitaxel.
Luo LM; Huang Y; Zhao BX; Zhao X; Duan Y; Du R; Yu KF; Song P; Zhao Y; Zhang X; Zhang Q
Biomaterials; 2013 Jan; 34(4):1102-14. PubMed ID: 23127332
[TBL] [Abstract][Full Text] [Related]
3. RGD-based strategies for improving antitumor activity of paclitaxel-loaded liposomes in nude mice xenografted with human ovarian cancer.
Zhao H; Wang JC; Sun QS; Luo CL; Zhang Q
J Drug Target; 2009 Jan; 17(1):10-8. PubMed ID: 19016068
[TBL] [Abstract][Full Text] [Related]
4. Antitumor effect of iRGD-modified liposomes containing conjugated linoleic acid-paclitaxel (CLA-PTX) on B16-F10 melanoma.
Du R; Zhong T; Zhang WQ; Song P; Song WD; Zhao Y; Wang C; Tang YQ; Zhang X; Zhang Q
Int J Nanomedicine; 2014; 9():3091-105. PubMed ID: 25028548
[TBL] [Abstract][Full Text] [Related]
5. Preparation, Characterization, and Pharmacokinetic Study of a Novel Long-Acting Targeted Paclitaxel Liposome with Antitumor Activity.
Han B; Yang Y; Chen J; Tang H; Sun Y; Zhang Z; Wang Z; Li Y; Li Y; Luan X; Li Q; Ren Z; Zhou X; Cong D; Liu Z; Meng Q; Sun F; Pei J
Int J Nanomedicine; 2020; 15():553-571. PubMed ID: 32158208
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxel-Loaded Folate-Coated pH-Sensitive Liposomes Enhance Cellular Uptake and Antitumor Activity.
Monteiro LOF; Fernandes RS; Castro L; Reis D; Cassali GD; Evangelista F; Loures C; Sabino AP; Cardoso V; Oliveira MC; Branco de Barros A; Leite EA
Mol Pharm; 2019 Aug; 16(8):3477-3488. PubMed ID: 31257891
[TBL] [Abstract][Full Text] [Related]
7. Co-delivery of epirubicin and paclitaxel using an estrone-targeted PEGylated liposomal nanoparticle for breast cancer.
Tang H; Chen J; Wang L; Li Q; Yang Y; Lv Z; Bao H; Li Y; Luan X; Li Y; Ren Z; Zhou X; Cong D; Liu Z; Jia J; Chen H; Zhao W; Meng Q; Sun F; Pei J
Int J Pharm; 2020 Jan; 573():118806. PubMed ID: 31678519
[TBL] [Abstract][Full Text] [Related]
8. The theranostic efficiency of tumor-specific, pH-responsive, peptide-modified, liposome-containing paclitaxel and superparamagnetic iron oxide nanoparticles.
Zheng XC; Ren W; Zhang S; Zhong T; Duan XC; Yin YF; Xu MQ; Hao YL; Li ZT; Li H; Liu M; Li ZY; Zhang X
Int J Nanomedicine; 2018; 13():1495-1504. PubMed ID: 29559778
[TBL] [Abstract][Full Text] [Related]
9. Liposomes encapsulating native and cyclodextrin enclosed paclitaxel: Enhanced loading efficiency and its pharmacokinetic evaluation.
Bhatt P; Lalani R; Vhora I; Patil S; Amrutiya J; Misra A; Mashru R
Int J Pharm; 2018 Jan; 536(1):95-107. PubMed ID: 29175440
[TBL] [Abstract][Full Text] [Related]
10. A novel localized co-delivery system with lapatinib microparticles and paclitaxel nanoparticles in a peritumorally injectable in situ hydrogel.
Hu H; Lin Z; He B; Dai W; Wang X; Wang J; Zhang X; Zhang H; Zhang Q
J Control Release; 2015 Dec; 220(Pt A):189-200. PubMed ID: 26474677
[TBL] [Abstract][Full Text] [Related]
11. Novel biocompatible intraperitoneal drug delivery system increases tolerability and therapeutic efficacy of paclitaxel in a human ovarian cancer xenograft model.
Vassileva V; Grant J; De Souza R; Allen C; Piquette-Miller M
Cancer Chemother Pharmacol; 2007 Nov; 60(6):907-14. PubMed ID: 17375303
[TBL] [Abstract][Full Text] [Related]
12. Paclitaxel in tyrosine-derived nanospheres as a potential anti-cancer agent: in vivo evaluation of toxicity and efficacy in comparison with paclitaxel in Cremophor.
Sheihet L; Garbuzenko OB; Bushman J; Gounder MK; Minko T; Kohn J
Eur J Pharm Sci; 2012 Feb; 45(3):320-9. PubMed ID: 22155544
[TBL] [Abstract][Full Text] [Related]
13. In vivo synergistic anti-tumor effect of paclitaxel nanoparticles combined with radiotherapy on human cervical carcinoma.
Yu Y; Xu S; You H; Zhang Y; Yang B; Sun X; Yang L; Chen Y; Fu S; Wu J
Drug Deliv; 2017 Nov; 24(1):75-82. PubMed ID: 28155566
[TBL] [Abstract][Full Text] [Related]
14. Improved Antitumor Activity of Novel Redox-Responsive Paclitaxel-Encapsulated Liposomes Based on Disulfide Phosphatidylcholine.
Du Y; Wang Z; Wang T; He W; Zhou W; Li M; Yao C; Li X
Mol Pharm; 2020 Jan; 17(1):262-273. PubMed ID: 31747284
[TBL] [Abstract][Full Text] [Related]
15. Antiangiogenic antitumor activity of HPMA copolymer-paclitaxel-alendronate conjugate on breast cancer bone metastasis mouse model.
Miller K; Eldar-Boock A; Polyak D; Segal E; Benayoun L; Shaked Y; Satchi-Fainaro R
Mol Pharm; 2011 Aug; 8(4):1052-62. PubMed ID: 21545170
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity of the bioreductive prodrug 3-(2-nitrophenyl) propionic acid-paclitaxel nanoparticles (NPPA-PTX NPs) on MDA-MB-231 cells: in vitro and in vivo.
Duan XC; Yao X; Zhang S; Xu MQ; Hao YL; Li ZT; Zheng XC; Liu M; Li ZY; Li H; Wang JR; Feng ZH; Zhang X
Int J Nanomedicine; 2019; 14():195-204. PubMed ID: 30636872
[TBL] [Abstract][Full Text] [Related]
17. Influence of formulation vehicle on metronomic taxane chemotherapy: albumin-bound versus cremophor EL-based paclitaxel.
Ng SS; Sparreboom A; Shaked Y; Lee C; Man S; Desai N; Soon-Shiong P; Figg WD; Kerbel RS
Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4331-8. PubMed ID: 16857808
[TBL] [Abstract][Full Text] [Related]
18. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo.
Lu J; Chuan X; Zhang H; Dai W; Wang X; Wang X; Zhang Q
Int J Pharm; 2014 Aug; 471(1-2):525-35. PubMed ID: 24858391
[TBL] [Abstract][Full Text] [Related]
19. Improved safety and efficacy of a lipid emulsion loaded with a paclitaxel-cholesterol complex for the treatment of breast tumors.
Ye J; Liu Y; Xia X; Meng L; Dong W; Wang R; Fu Z; Liu H; Han R
Oncol Rep; 2016 Jul; 36(1):399-409. PubMed ID: 27175803
[TBL] [Abstract][Full Text] [Related]
20. Paclitaxel-loaded folate-coated long circulating and pH-sensitive liposomes as a potential drug delivery system: A biodistribution study.
Monteiro LOF; Fernandes RS; Oda CMR; Lopes SC; Townsend DM; Cardoso VN; Oliveira MC; Leite EA; Rubello D; de Barros ALB
Biomed Pharmacother; 2018 Jan; 97():489-495. PubMed ID: 29091899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
